Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind, placebo-controlled, randomised clinical study of Broncho-Vaxom drops in children with recurrent respiratory tract infections
2009-013378-42Phase 3Completed
- Sponsor
- OM Pharma
- Start
- Jun 2010
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in recurrent respiratory tract infection (RRTI) comparing Broncho-Vaxom drops with Placebo (2 arms). Primary endpoints: Proportion of patients with recurrent RTIs and Efficacy and safety of Broncho-Vaxom drops. Started Jun 2010; status: completed.
02
Drugs
OM-85
03
Conditions
recurrent respiratory tract infection (RRTI)
Beyond the preview
Go deeper on 2009-013378-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013378-42.